Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy

Biomarkers. 2012 Nov;17(7):648-54. doi: 10.3109/1354750X.2012.713004. Epub 2012 Aug 20.

Abstract

Context: Vascular endothelial growth factor (VEGF) plays a role in asthma and pathological pregnancies.

Objective: This is the first study assessing plasma and exhaled breath condensate VEGF levels in asthmatic pregnancy.

Material and methods: Thirty-one asthmatic pregnant, 29 asthmatic nonpregnant, 28 healthy pregnant and 22 healthy nonpregnant women were enrolled. Plasma was collected in all subjects, EBC in 57 volunteers for VEGF measurements.

Results: Plasma VEGF decreased in both pregnant groups (p < 0.01), without any differences between the asthmatic and the respective nonasthmatic groups (p > 0.05). VEGF was undetectable in EBC.

Conclusion: Concomitant asthma does not affect plasma VEGF during pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asthma / blood*
  • Biomarkers / blood
  • Biomarkers / chemistry
  • Birth Weight
  • Breath Tests
  • Case-Control Studies
  • Exhalation
  • Female
  • Gases / chemistry
  • Humans
  • Infant, Newborn
  • Limit of Detection
  • Pregnancy
  • Pregnancy Complications / blood*
  • Vascular Endothelial Growth Factor A / blood*
  • Vascular Endothelial Growth Factor A / chemistry
  • Vascular Endothelial Growth Factor Receptor-1 / blood
  • Young Adult

Substances

  • Biomarkers
  • Gases
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1